Genovac Enters Exclusive Licensing Agreement with Pfizer for Therapeutic Antibody Candidates
Pfizer to obtain exclusive worldwide rights to develop and commercialize antibodies from Genovac academic collaboration. FARGO, NORTH DAKOTA, UNITED STATES OF AMERICA, September 19, 2023 /EINPresswire.com/ -- Genovac, a leading contract research …